AN2 Therapeutics, Inc. (ANTX) Insider Trading

Name: AN2 Therapeutics, Inc. (ANTX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 16, 2026): Trenor Cameron C. III (Chief Medical Officer): Grant/Award of 116,667 shares.

Get alerted when insiders trade ANTX

Email address

Loading company data...

Beta

Loading company details...

Beta